Researchers reveal how DICER precisely processes RNA using dual binding pockets, ensuring accurate gene silencing, and ...
One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.
Morning Overview on MSN
How a rogue RNA protein hacks bad codons to hijack human cells?
A team at UT Southwestern Medical Center has identified a structural trick that lets viruses translate their genetic code inside human cells, even when that code is riddled with “bad” codons the host ...
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, using artificial ...
StockStory.org on MSN
Therapeutics stocks Q4 teardown: Moderna (NASDAQ:MRNA) vs the rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and ...
A new study has for the first time elucidated the gut-liver immune regulatory axis jointly maintained by intestinal commensal bacteria and the intestinal endocrine system, and uncovered the ...
February was a light month for agency and consultancy news, but a few interesting changes came through. Read on for the ...
NEWS10 ABC on MSN
UAlbany researchers develop new technique to test mRNA vaccines
ALBANY, NY (News10) – Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...
An AI model that screens ionizable lipids by 3D conformation identified a candidate 14.8 times more efficient than current ...
Reuters Antitrust Correspondent Jody Godoy interviews FTC Bureau of Competition Director Daniel Guarnera at Reuters Pharma USA this week in Philadelphia. With patent cliffs approaching and plenty of ...
Researchers developed lipid nanoparticles delivering an IDO-blocking drug, and mRNA to boost immune signaling. This dual action revives exhausted T cells, eliminates tumors in models, and may enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results